Please check your internet connection and try again.
# Sinex (oxymetazoline)
## Overview
Oxymetazoline is an alpha-adrenergic agonist that acts as a topical decongestant. It causes vasoconstriction of the nasal mucosa, reducing swelling and congestion.
## Primary Indications
* Nasal congestion associated with the common cold, allergic rhinitis, or sinusitis.
## Adult Dosing
* **Nasal spray:** 2 sprays in each nostril every 10-12 hours as needed.
* **Maximum:** Do not use for more than 3 consecutive days.
## Pediatric Dosing
* **Children 6 to under 12 years:** 1-2 sprays in each nostril every 10-12 hours as needed.
* **Children under 6 years:** Use is not recommended. Consult a pediatrician.
## Dose Adjustments
No dose adjustments are typically needed based on renal or hepatic impairment.
## Contraindications
* Hypersensitivity to oxymetazoline or any component of the formulation.
* Patients with narrow-angle glaucoma.
* Use with MAO inhibitors or within 2 weeks of discontinuing MAO inhibitors.
## Adverse Effects
* **Common:** Nasal discomfort, burning, stinging, sneezing, dry nose.
* **Less Common/Serious:** Rebound congestion (rhinitis medicamentosa) with prolonged use, hypertension, headache, nervousness, insomnia, palpitations.
## Key Drug Interactions
* **MAO Inhibitors:** Can potentiate hypertensive effects. Avoid concomitant use.
* **Tricyclic Antidepressants (TCAs):** May potentiate the pressor response. Use with caution.
## Monitoring
* Monitor for signs of rebound congestion (worsening congestion upon cessation of use).
* Monitor blood pressure and heart rate, especially in patients with cardiovascular disease or in those using chronically (though this is not recommended).
## Clinical Pearls
* Limit use to a maximum of 3 consecutive days to minimize the risk of rebound congestion.
* If congestion persists beyond 3 days, discontinue oxymetazoline and consult a healthcare provider.
* Proper administration technique (tilting head slightly forward) is important for effective delivery.
***
**Disclaimer:** This information is intended for clinical decision support and does not replace comprehensive drug information resources or professional judgment. Always verify current prescribing information, guidelines, and patient-specific factors before making treatment decisions.
